| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Beone Medicines AG's insiders have reduced their positions by a net 345,345 shares worth roughly $123.6M. In the past 30 days, 0 insiders bought and 1 sold. The bias lately has been to the sell side.
Classified under Biotechnology (Health Care sector), BEIGF's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 8.10M | $298.29M | - | |
| Dir | 0 | - | -31,027 | |
| VP | 0 | - | - | |
| Other | 0 | - | - | |
| COO | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 13, 2026 | Wang Xiaodong58 | Director, Chair, Scientific Advisory Brd | Sale+OE10b5-1 | 31,027 | $350.99 | $10,890,073.93 | - | |
| Sep 30, 2026 | Lee Chan Henry49 | SVP, General Counsel | Sell10b5-1 | 1,115 | $375.00 | $418,125.00 | -100% | |
| Sep 28, 2026 | Wang Xiaodong58 | Director, Chair, Scientific Advisory Brd | Sale+OE10b5-1 | 31,028 | $364.79 | $11,318,557.97 | - | |
| Sep 8, 2026 | Wang Xiaodong58 | Director, Chair, Scientific Advisory Brd | Sale+OE10b5-1 | 38,287 | $349.10 | $13,366,091.76 | - | |
| Sep 1, 2026 | Ball Titus B. | Principal Accounting Officer | Sell | 132 | $355.86 | $46,973.52 | -100% | |
| Aug 25, 2026 | Wu Xiaobin52 | President and COO | Sell10b5-1 | 280 | $380.00 | $106,400.00 | -100% | |
| Aug 12, 2026 | Oyler John58 | Chief Executive Officer | Sell10b5-1 | 240,810 | $359.12 | $86,480,472.01 | -100% | |
| Aug 11, 2026 | Lee Chan Henry49 | SVP, General Counsel | Sale+OE10b5-1 | 2,666 | $360.00 | $959,760.00 | - | |
| Aug 3, 2026 | Rosenberg Aaron | Chief Financial Officer | Sell | 1,157 | $312.72 | $361,811.25 | -100% | |
| Jul 30, 2026 | Lee Chan Henry49 | SVP, General Counsel | Sell | 1,044 | $323.69 | $337,932.36 | -100% |